Evogene (EVGN) Q1 2025 Earnings
EVGN·Reported May 21, 2025·Before market open
Evogene reported Q1 2025 revenue of $2.4M (-41.7% YoY), beat analyst consensus of $1.9M by $501.5K. Diluted EPS came in at $-0.38 (+52.5% YoY), beat the $-0.63 consensus by $0.24.
Revenue
$2.4Mbeat by $501.5K
Consensus: $1.9MDiluted EPS
$-0.38beat by $0.24
Consensus: $-0.63
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about Evogene's Q1 2025 earnings report.
Evogene (EVGN) reported Q1 2025 earnings on May 21, 2025 before market open.
Evogene reported revenue of $2.4M and diluted EPS of $-0.38 for Q1 2025.
Revenue beat the consensus estimate of $1.9M by $501.5K. EPS beat the consensus estimate of $-0.63 by $0.24.
Compared to the same quarter a year prior, revenue declined 41.7% from $4.2M a year earlier and diluted EPS grew 52.5% from $-0.80.